Aug
14

UPS deal with Gallagher Bassett

Several industry sources indicate UPS has decided to move about a quarter of its workers compensation business from Liberty Mutual to TPA Gallagher Bassett. The transition date is 1/1/2007.
UPS has been with Liberty from the beginning, and this represents a significant loss, as both claims administration and managed care will be moved to GB.
This is a major win for GB, and may mean that the big TPA has revised its business practices and cleaned up its act. GB has had a few embarassments in the marketplace of late, notably the Broward County School Board fiasco. UPS’ adviser is Aon, a consulting/brokerage house I have been less than impressed with in the past; perhaps Aon, which developed a managed care contracting and evaluation strategy as a direct result of its consulting work at a very large payer, has also upgraded its talent and output.
It appears the rationale was UPS’ desire to reduce the number of eggs per basket. It remains to be seen if the folks in brown have used the right approach and picked a decent basket.


Aug
11

First Health’s work comp financials

Coventry’s First Health unit enjoyed an uptick in workers comp revenues in 2006 from Q1 to Q2, but revenues have been essentially flat over the last five quarters.
Here are the work comp division’s revenue numbers (in millions of dollars)
2005 Q2 $54
2005 Q3 $51
2005 Q4 $53
2006 Q1 $51
2006 Q2 $55
Overall, the entire FH division (work comp, commercial, and other lines) has seen declining revenues, from $224 million in Q2 2005 to $215 million in the most recent quarter. Note that the most recent 10-Q filing indicates revenues have gone up appreciably from the first half of 2005 to this year; this is partly because the acquisition did not close until January 28 2005, making revenue numbers from that quarter artificially low.
More on First Health is here.


Aug
10

Work comp Rx news

News reports indicate Amerisource Bergen (ABC), the hospital supply firm, is unloading its Pharmerica subsidiary. Actually, it is forming a joint venture with Kindred Healthcare to combine both companies’ long term care businesses in a new entity.
These companies provide drugs and supplies to nursing homes around the country, have annual combined sales of $1.9 billion and rather thin profits of $75 million.
Pharmerica also was the parent company of workers comp PBM Tmesys/PMSI, which evidently is staying within the ABC company fold.
Last week PMSI/Tmesys also made several changes in management, including promoting Mark Hollifield to president to replace Dave Weidner, who moved on to another senior position within the parent company. Hollifield, who was promoted to COO at the end of March 2006, is a well-regarded manager. Tamara Wagner, the long-time head of sales departed as well, and an interim sales leader was appointed from within.
Other sources indicate Coventry’s First Health unit is looking into entering the WC PBM business, likely by going the acquisition route.


Aug
10

Illegal money laundering? Just say “Noe”

In the “we could not make this stuff up” category, former Ohio coin dealer/money manager Tom Noe (!) is set to be sentenced on September 12 for funneling illegal campaign contributions to the Bush re-election campaign . Noe is likely to spend upwards of two years in prison, and perhaps a lot “upwards”. The funds totaled $42,000, and helped Noe attain the coveted “Pioneer” status in the Bush campaign.
The bad news won’t end there for Noe; several weeks after his sentencing he will begin defending himself against separate charges filed by the state of Ohio relating to his alleged theft from the reserves of Ohio’s Bureau of Workers Compensation. For those who have not been following Noe’s transgressions, be advised, the man was pretty busy.


Aug
3

More on drugs in workers comp

Drugs account for over one-eighth of workers compensation medical expenses, and that number continues to increase. The data from NCCI’s latest research paper on workers compensation drug costs is consistent with the findings of my firm’s research, and provides additional detail on the specific drugs that account for the majority of dollars spent.
NCCI’s report includes results up to 2003; while there have been several significant changes since then (the disappearance of most of the COX-2s, patent expiration on Oxycontin, and the explosive growth of Actiq), the report’s year-over-year trend data is sobering.
Of note, experience indicates that the most sophisticated payers are holding increases in the 2-5% range through the use of clinical management programs, data mining, adjuster training, strong EDI connections, and intelligent third party biller strategies.
Their less-sophisticated colleagues are at the other end of the spectrum, experiencing 15% and higher annnual inflation rates.
What does this mean for you?
If you aren’t working hard on this, you may want to get started.


Jul
23

Drugs in Workers Comp – Survey Report

My firm’s third annual survey of prescription drug management in workers comp has been completed, and here are a few of the findings.
1. Drug costs increased slightly more than 10% last year, a “decrease in the rate of increase” over prior years.
2. Respondents, which ranged from small regional payers to the largest national insurers, are getting more sophisticated about drugs and drug management. This is evidenced by respondents’ increasing focus on clinical management programs; access to more and better data about their programs and results thereof; and greater attention on utilization vs. price.
3. Third party billers continue to frustrate payers, with almost 90% viewing TPBs as problematic. Concerns included reduced data quality, increased administrative problems and workload, and increased costs.
4. Drug repackaging is also high on respondents’ lists of problems, with particular emphasis on the California situation and physician dispensing.
A copy of the survey report can be obtained by emailing me at jpaduda@healthstrategyassoc.com


Jun
29

Surgical implants – who’s paying?

Physicians choose surgical implants and devices, hospitals order and pay for them, patients get whatever the docs choose, device manufacturers make lots of profits, and payers foot the bill. A process that is seemingly designed to completely avoid any price sensitivity, and the results to date have shown that there is remarkably little concern about cost on the part of the doc or patient, and at least to date, little ability to reduce costs on the part of the hospital, or payer.
A column in today’s New York Times describes the results of an analysis performed by investment firm Sanford Bernstein (registration required) which compared the costs of surgical implants (artificial hips, knees, etc) at 100 hospitals. Many of these institutions thought they were getting preferential pricing, but the results of the study show that their costs may have been substantially higher than other hospitals’.
The net of the article is that the days of price opacity in surgical implants is likely coming to an end; the research, combined with inquiries by regulators and the US Justice Dept. will shine a blinding light on the arcane world of implant pricing, likely bringing to an end the annual 8% price increases.
There is a subtlety missed in the article, which pertains to the small but important role of the workers comp payer. Sources indicate that a substantial portion of surgical implants are covered by workers comp, a portion much greater than the miniscule overall market share of comp (about 2% of all medical dollars are spent on comp, but figures indicate over a third of surgical implants are paid for under workers comp).
In comp, specifically in DRG states like New York, the cost of the implant is added to the DRG cost, which can increase the cost of the care by 50-70%. Therefore, the wounded parties in comp are not the hospitals (who typically price these procedures on a bundled basis in the group health and Medicare worlds and thereby absorb the cost) but the WC insurers.
What does this mean for you?
More light shining on the murky world of medical costs and procedures is always welcome; be sure to make sure you understand how the bundling and unbundling applies to your contracts and reimbursement.


Jun
19

Ohio’s BWC to cut payments to hospitals

Ohio’s Bureau of Workers Compensation will no longer be subsidizing indigent care at the state’s hospitals. The recent announcement that BWC is cutting reimbursement for inpatient care to Medicare plus 15% is one of the positive outcomes of the Hydra-headed scandal at Ohio’s Bureau of Workers Compensation.
And it appears likely that BWC will next cut payments for outpatient services, which make up a much larger slice of the medical expense pie.
Ohio joins several other states, including Pennsylvania. Connecticut, Rhode Island, California, and Maryland, all of which base workers comp reimbursement on Medicare costs plus a percentage.
Notably, the press has been somewhat neutral in its coverage of the change, with a recent editorial allowing that the reduction will simply result in cost-shifting to other payers. That is an inevitable result; however there is no logical, ethical, or legal requirement that the state’s employers pay for the inefficiencies or hospitals or society’s failure to provide insurance for all citizens.
Work comp has been a very profitable line of business for the state’s hospitals, generating over a half-billion dollars over a seven year period. That figure covers both inpatient and outpatient care, with outpatient significantly larger.
What does this mean for you?
On a micro level, lower costs for workers comp in Ohio; on a macro level another push for universal coverage.


Jun
16

The smart money is buying TPAs

Sedgwick CMS, one of the nation’s larger property and casualty TPAs, is getting even bigger. The company will be acquiring Comp Management Inc. (CMI) for just under $200 million.
This marks the first expansion of Sedgwick since its sale to Fidelity National earlier in the year. Sedgwick acquired California-based disability management and administration firm VPA in May. Prior to that deal, Sedgwick had primarily grown organically; the new owners look to be very interested in gaining size and competencies as quickly as possible.
CMI had been on an expansion trajectory of its own, branching out into medical malpractice administration with the acquisition of Octagon in 2003, a deal that also significantly expanded CMI’s west coast presence. CMI was owned by investment firm Security Capital Corp. of Greenwich Ct.
Broadspire is another TPA acquired by an investment firm. This deal, which transferred the somewhat-damaged Kemper National Services TPA to Platinum Equity, was the first of a series of acquisitions that have propelled the combined entity into the top tier of TPAs in terms of market size. RSKCO and Cunningham Lindsey were added to the portfolio in 2004. Since that deal, Broadspire has been selling off assets that appear to be tangential to its core claims adjudication business; the disability management operation went to Aetna and Bureau Veritas picked up the loss control/safety division earlier this year.
These deals are not the only sign of interest on the part of the investment community in the P&C world. The level and amount of interest in TPAs has grown exponentially over the past year; my sense is the industry is perceived to be ripe for consolidation; backward in terms of technology, business process streamlining, and operational excellence; and significantly less profitable than it could be.
I agree.